JNK mediates TGF-β1-induced epithelial mesenchymal transdifferentiation of mouse transformed keratinocytes

FEBS Letters

Volumn 580, Issue 22, 2006, Pages 5385-5391

  Santibañez, Juan F ^a  

^a UNIVERSITY OF CHILE   (Chile)

Author keywords

EMT; JNK; Keratinocytes; TGF 1; uPA

Indexed keywords

ACTIN; ANTHRA[1,9 CD]PYRAZOL 6(2H) ONE; ANTISENSE OLIGODEOXYNUCLEOTIDE; FIBRONECTIN; MITOGEN ACTIVATED PROTEIN KINASE P38; STRESS ACTIVATED PROTEIN KINASE; STRESS ACTIVATED PROTEIN KINASE 1; TRANSFORMING GROWTH FACTOR BETA1; UROKINASE; UVOMORULIN; VIMENTIN;

ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CELL MIGRATION; CELL STIMULATION; CELL TRANSFORMATION; CONTROLLED STUDY; ENZYME ACTIVATION; EPITHELIUM CELL; KERATINOCYTE; MESENCHYME CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION;

ANIMALS; CADHERINS; CELL DIFFERENTIATION; CELL LINE, TRANSFORMED; CELL MOVEMENT; CELL TRANSFORMATION, NEOPLASTIC; FIBRONECTINS; GENE EXPRESSION REGULATION; KERATINOCYTES; MAP KINASE KINASE 4; MICE; MITOGEN-ACTIVATED PROTEIN KINASE 8; MITOGEN-ACTIVATED PROTEIN KINASE 9; PROTEIN TRANSPORT; PROTO-ONCOGENE PROTEINS C-JUN; SIGNAL TRANSDUCTION; TRANS-ACTIVATION (GENETICS); TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1; URINARY PLASMINOGEN ACTIVATOR; VIMENTIN;

EID: 33748776858     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.febslet.2006.09.003     Document Type: Article

References (36)

1. Hanahan D., and Weinberg R.A. The hallmarks of cancer. Cell 100 1 (2000) 57-70
2. Martinez-Arias A. Epithelial mesenchymal interactions in cancer development. Cell 105 (2001) 425-431
3. Massague J., and Wotton D. Transcriptional control by the TGF-beta/Smad signaling system. EMBO J. 19 8 (2003) 1745-1754
4. Dennler S., Goumans M.J., and ten Dijke P. Transforming growth factor beta signal transduction. J. Leukoc. Biol. 71 5 (2002) 731-740
5. Shi Y., and Massague J. Mechanisms of TGF-beta signaling from cell membrane to the nucleus. Cell 113 6 (2003) 685-700
6. Derynck R., and Zhang Y.E. Smad-dependent and Smad-independent pathways in TGF-beta family signalling. Nature 425 6958 (2003) 577-584
7. Mulder K.M., and Morris S.L. Activation of p21ras by transforming growth factor beta in epithelial cells. J. Biol. Chem. 267 8 (1992) 5029-5031
8. Iglesias M., Frontelo P., Gamallo C., and Quintanilla M. Blockade of Smad4 in transformed keratinocytes containing a Ras oncogene leads to hyperactivation of the Ras-dependent Erk signalling pathway associated with progression to undifferentiated carcinomas. Oncogene 19 36 (2000) 4134-4145
9. MT, Mulder KM. 1997. Transforming growth factor-beta signaling in epithelial cells. Pharmacol Ther. 75(1):21-41.
10. Santibanez J.F., Iglesias M., Frontelo P., Martinez J., and Quintanilla M. Involvement of the Ras/MAPK signaling pathway in the modulation of urokinase production and cellular invasiveness by transforming growth factor-beta(1) in transformed keratinocytes. Biochem. Biophys. Res. Commun. 273 2 (2000) 521-527
11. Frey R.S., and Mulder K.M. Involvement of extracellular signal-regulated kinase 2 and stress-activated protein kinase/Jun N-terminal kinase activation by transforming growth factor β in the negative growth control of breast cancer cells. Cancer Res. 57 (1997) 628-633
12. Zhou G., Lee S.C., Yao Z., and Tan T.H. Hematopoietic progenitor kinase 1 is a component of transforming growth factor beta-induced c-Jun N-terminal kinase signaling cascade. J. Biol. Chem. 274 19 (1999) 13133-13138
13. Roberts A.B., and Wakefield L.M. The two faces of transforming growth factor beta in carcinogenesis. Proc. Natl. Acad. Sci. USA 100 15 (2003) 8621-8623
14. Oft M., Heider K.H., and Beug H. TGFbeta signaling is necessary for carcinoma cell invasiveness and metastasis. Curr. Biol. 8 23 (1998) 1243-1252
15. Caulin C., Scholl F.G., Frontelo P., Gamallo C., and Quintanilla M. Chronic exposure of cultured transformed mouse epidermal cells to transforming growth factor-beta 1 induces an epithelial-mesenchymal transdifferentiation and a spindle tumoral phenotype. Cell Growth Differ. 6 8 (1995) 1027-1035
16. Oft M., Peli J., Rudaz C., Schwarz H., Beug H., and Reichmann E. TGF-beta1 and Ha-Ras collaborate in modulating the phenotypic plasticity and invasiveness of epithelial tumor cells. Genes Dev. 10 19 (1996) 2462-2477
17. De Cesare D., Vallone D., Caracciolo A., Sassone-Corsi P., Nerlov C., and Verde P. Heterodimerization of c-Jun with ATF-2 and c-Fos is required for positive and negative regulation of the human urokinase enhancer. Oncogene 11 2 (1995) 365-376
18. Himelstein B.P., Lee E.J., Sato H., Seiki M., and Muschel R.J. Transcriptional activation of the matrix metalloproteinase-9 gene in an H-ras and v-myc transformed rat embryo cell line. Oncogene 14 16 (1997) 1995-1998
19. Karin M. The regulation of AP-1 activity by mitogen-activated protein kinases. Philos. Trans. R Soc. Lond. B Biol. Sci. 351 1336 (1996) 127-134
20. Piek E., Moustakas A., Kurisaki A., Heldin C.H., and ten Dijke P. TGF-(beta) type I receptor/ALK-5 and Smad proteins mediate epithelial to mesenchymal transdifferentiation in NMuMG breast epithelial cells. J. Cell Sci. 112 Pt 24 (1999) 4557-4568
21. Oft M., Akhurst R.J., and Balmain A. Metastasis is driven by sequential elevation of H-ras and Smad2 levels. Nat. Cell Biol. 4 7 (2002) 487-494
22. Diaz-Guerra M., Haddow S., Bauluz C., Jorcano J.L., Cano A., Balmain A., and Quintanilla M. Expression of simple epithelial cytokeratins in mouse epidermal keratinocytes harboring Harvey ras gene alterations. Cancer Res. 52 3 (1992) 680-687
23. Thiery J.P. Epithelial-mesenchymal transitions in tumour progression. Nat. Rev. Cancer 2 6 (2002) 442-454
24. Boyer B., Valles A.M., and Edme N. Induction and regulation of epithelial-mesenchymal transitions. Biochem. Pharmacol. 60 8 (2000) 1091-1099
25. Gotzmann J., Mikula M., Eger A., Schulte-Hermann R., Foisner R., Beug H., and Mikulits W. Molecular aspects of epithelial cell plasticity: implications for local tumor invasion and metastasis. Mutat. Res. 566 1 (2004) 9-20 Review
26. Yue J., Sun B., Liu G., and Mulder K.M. Requirement of TGF-beta receptor-dependent activation of c-Jun N-terminal kinases (JNKs)/stress-activated protein kinases (Sapks) for TGF-beta up-regulation of the urokinase-type plasminogen activator receptor. J. Cell Physiol. 199 2 (2004) 284-292
27. Itoh S., Thorikay M., Kowanetz M., Moustakas A., Itoh F., Heldin C.H., and ten Dijke P. Elucidation of Smad requirement in transforming growth factor-beta type I receptor-induced responses. J. Biol. Chem. 278 6 (2003) 3751-3761
28. Tanaka Y., Kobayashi H., Suzuki M., Kanayama N., and Terao T. Transforming growth factor-beta1-dependent urokinase up-regulation and promotion of invasion are involved in Src-MAPK-dependent signaling in human ovarian cancer cells. J. Biol. Chem. 279 10 (2004) 8567-8576
29. Miralles F., Parra M., Caelles C., Nagamine Y., Felez J., and Munoz-Canoves P. UV irradiation induces the murine urokinase-type plasminogen activator gene via the c-Jun N-terminal kinase signaling pathway: requirement of an AP1 enhancer element. Mol. Cell Biol. 18 8 (1998) 4537-4547
30. Hocevar B.A., Brown T.L., and Howe P.H. TGF-beta induces fibronectin synthesis through a c-Jun N-terminal kinase-dependent, Smad4-independent pathway. EMBO J. 18 5 (1999) 1345-1356
31. Otto I.M., Raabe T., Rennefahrt U.E., Bork P., Rapp U.R., and Kerkhoff E. The p150-Spir protein provides a link between c-Jun N-terminal kinase function and actin reorganization. Curr. Biol. 10 6 (2000) 345-348
32. Bissell M.J., and Radisky D. Putting tumours in context. Nat. Rev. Cancer. 1 1 (2001) 46-54
33. Christofori G., and Semb H. The role of the cell-adhesion molecule E-cadherin as a tumour-suppressor gene. Trends Biochem. Sci. 24 2 (1999) 73-76
34. Birchmeier W., and Behrens J. Cadherin expression in carcinomas: role in the formation of cell junctions and the prevention of invasiveness. Biochim. Biophys. Acta. 1198 1 (1994) 11-26
35. Dandachi N., Hauser-Kronberger C., More E., Wiesener B., Hacker G.W., Dietze O., and Wirl G. Co-expression of tenascin-C and vimentin in human breast cancer cells indicates phenotypic transdifferentiation during tumour progression: correlation with histopathological parameters, hormone receptors, and oncoproteins. J. Pathol. 193 2 (2001) 181-189
36. Nagata Y., Takahashi N., Davis R.J., and Todokoro K. Activation of p38 MAP kinase and JNK but not ERK is required for erythropoietin-induced erythroid differentiation. Blood 92 6 (1998) 1859-1869